Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): John Jose , Gert Richardt , Mohamed Abdel-Wahab Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has undergone tremendous technological advancements since the first successful implantation in 2002 for symptomatic severe aortic valve stenosis (AS).1 It is currently considered as the standard of care for severe AS patients who have high surgical risk or may be deemed unsuitable for surgery.2 Broadly, there are two main categories of transcatheter… View more
Author(s): Howard C Herrmann Added: 1 week ago
ACC.24 — Investigator, Dr Howard C Hermann (Penn Medicine, Philadelphia, PA, US) joins us to discuss the findings from the SMART Trial (NCT04722250).This prospective, multi-center, randomized controlled study aims to investigate the valve safety and performance of self expanding as compared to balloon-expandable transcatheter aortic valve replacement (TAVR) in patients with small aortic annuli… View more
Author(s): Didier Tchétché Added: 1 week ago
Dr Didier Tchétché (Clinique Pasteur, Toulouse, FR) joins us to discuss findings from the SMART Trial.This prospective, multi-centre, randomised controlled study aims to investigate the valve safety and performance of self expanding as compared to balloon-expandable transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli and severe symptomatic aortic stenosis. At… View more
Author(s): Holger Thiele Added: 5 years ago
Prof Holger Thiele (Leipzig Heart Center, Leipzig, DE) discusses SOLVE-TAVI - A 2x2 randomised trial of self-expandable vs balloon-expandable valves and general vs local anasthesia in patients undergoing transcatheter aortic valve implantation. Filmed by Radcliffe Cardiology on site at TCT 2018. View more
Author(s): Grégory Ducrocq , Dominique Himbert , Eric Brochet , et al Added: 3 years ago
Aortic stenosis (AS) is currently the most frequent native valve disease in Europe and is most often seen in elderly patients with co-morbidities.1 Valve replacement is the definitive therapy for patients with severe AS who have symptoms or objective consequences such as left ventricular (LV) dysfunction.2,3 However, the risk of surgery may be higher in elderly patients with significant co… View more
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 1 year ago
Learn about the key take-home messages from EuroPCR 2022 with View from the Thoraxcenter hosts, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this succinct review video, they summarise the top late-breaking science trials and share their take on how the new data can be translated into practice. Trials covered in detail include: 00:54: Descision… View more
Author(s): Fausto Castriota , Armando Liso , Giancarlo Biamino , et al Added: 3 years ago
Carotid angioplasty and stenting (CAS) is becoming a frequent therapeutic strategy for approaching severe carotid obstructive disease and is now widely accepted as a less invasive technique that provides an attractive alternative for many patients, particularly those with significant co-morbidities.1–6 From a technical standpoint, the continuous evolution of carotid stent design increases the… View more
Foreword

Article

Author(s): Simon Kennon Added: 3 years ago
This issue of Interventional Cardiology Review contains papers by leading proponents of both FFR and iFR. This is a complex field and I am delighted to have experts presenting their detailed but differing interpretations of the available data relating to these important technologies. Advances in both techniques and technology have transformed chronic total occlusion interventions over the last… View more
Author(s): Eduardo A Arias , Amit Bhan , Zhan Lim , et al Added: 3 years ago
During the past decade, transcatheter aortic valve implantation (TAVI) has revolutionised the interventional treatment of aortic stenosis (AS).1 It has rapidly evolved from a treatment used on a compassionate basis for inoperable patients to being the standard of care in high-risk AS.2,3 In that cohort it has proven to be non-inferior to surgical aortic valve replacement (SAVR) in terms of… View more